Literature DB >> 3135097

Osteodystrophy of diabetics in chronic dialysis: a histomorphometric study.

J Aubia1, S Serrano, L Mariñoso, L Hojman, A Diez, J Lloveras, J Masramon.   

Abstract

A decreased incidence of hyperparathyroidism in diabetic uremic patients has been reported, but comprehensive bone histomorphometric studies on uremic diabetic osteodistrophy are scarce. We present here the results of static and dynamic bone morphometry in 13 diabetic patients on dialysis (DCD) and their comparison with a pair-matched group of nondiabetic uremics with similar age, sex, and time on dialysis (NCDC), and with a group of 17 normals (N). Diabetic bone showed: (1) Low trabecular volume (Vt 9.9% in DCD and 22.8% in N), (2) Moderately increased remodeling values of intermediate intensity between N and NDCD values (Sf = 19.3% in DCD, 37.4% in NDCD, and 8.8 +/- 6% in N, Sr = 4.3% in DCD, 7.3% in NDCD and 2.04 +/- 0.9% in N), and (3) Moderate fibrosis (Sfib 1.2% in DCD, 12.9% in NDCD). Besides these confirmatory results, two suggestions emerged from the study: (1) The relative number of cells: osteoclast density (OI) and osteoblasts (Ob/OID) appears to be lower, not only than NDCD values but also lower than N values (OI = 0.04 c/mm. in DCD, 0.31 in NDCD, and 0.14 in N; Ob/OID = 5.58% in DCD, 14.6 in NDCD and 22.12 +/- 9% m N). (2) Dynamic behavior in tetracycline based studies disclosed the appearance of two populations of DCD: a subgroup of preserved calcification dynamics with values not quite different than the NDCD group and a subgroup with a significant derangement of mineralization with no measurable bone trabecular dynamics. This late subgroup also showed significantly lower number of Ob/OID values compared with the former with preserved calcification.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1988        PMID: 3135097     DOI: 10.1007/bf02556363

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  28 in total

1.  Correction of abnormal bone and mineral metabolism in chronic streptozotocin-induced diabetes mellitus in the rat by insulin therapy.

Authors:  S Hough; L V Avioli; M A Bergfeld; M D Fallon; E Slatopolsky; S L Teitelbaum
Journal:  Endocrinology       Date:  1981-06       Impact factor: 4.736

2.  Osteopenia during long-term haemodialysis: response to vitamin D3 analogues.

Authors:  N Muirhead; S Adami; R A Fraser; G R Catto; N Edward; J L O'Riordan
Journal:  Proc Eur Dial Transplant Assoc       Date:  1981

3.  Decreased cortical thickness & osteopenia in children with diabetes mellitus.

Authors:  J V Santiago; W H McAlister; S K Ratzan; Y Bussman; M W Haymond; G Shackelford; V V Weldon
Journal:  J Clin Endocrinol Metab       Date:  1977-10       Impact factor: 5.958

4.  Abnormalities in the biosynthesis of cartilage and bone proteoglycans in experimental diabetes.

Authors:  R E Weiss; A H Gorn; M E Nimni
Journal:  Diabetes       Date:  1981-08       Impact factor: 9.461

5.  Relative hyperphosphaturia in diabetic chronic renal failure: a protective factor of hyperparathyroidism.

Authors:  J Aubia; J Bosch; J Lloveras; M Chine; L Hojman; J Masramon
Journal:  Miner Electrolyte Metab       Date:  1987

6.  Influence of experimental diabetes and insulin on matrix-induced cartilage and bone differentiation.

Authors:  R E Weiss; A H Reddi
Journal:  Am J Physiol       Date:  1980-03

7.  Decreased secondary hyperparathyroidism in diabetic patients receiving hemodialysis.

Authors:  F Vincenti; R Hattner; W J Amend; N J Feduska; R M Duca; O Salvatierra
Journal:  JAMA       Date:  1981-03-06       Impact factor: 56.272

8.  Low incidence of hyperparathyroidism in diabetic renal failure.

Authors:  J Aubia; J Bosch; J Lloveras; L Mariñoso; J Masramon; S Serrano; X Cuevas; A Orfelia; I Llorach; M Llorach
Journal:  Proc Eur Dial Transplant Assoc Eur Ren Assoc       Date:  1985

9.  Lower parathyroid hormone and creatinine in diabetic uremia.

Authors:  M M Avram
Journal:  Contrib Nephrol       Date:  1980       Impact factor: 1.580

10.  A prospective study of bone mass in patients with type I diabetes.

Authors:  S L Hui; S Epstein; C C Johnston
Journal:  J Clin Endocrinol Metab       Date:  1985-01       Impact factor: 5.958

View more
  7 in total

1.  Diabetic bone disease.

Authors:  R Bouillon
Journal:  Calcif Tissue Int       Date:  1991-09       Impact factor: 4.333

2.  Effect of targeted delivery of bone morphogenetic protein-2 on bone formation in type 1 diabetes.

Authors:  Ronaldo Barcellos de Santana; Phillip C Trackman
Journal:  Int J Oral Maxillofac Implants       Date:  2015 May-Jun       Impact factor: 2.804

3.  Mineral abnormalities and long-term graft function in pediatric renal transplant recipients: a role for FGF-23?

Authors:  Katherine Wesseling-Perry; Eileen W Tsai; Robert B Ettenger; Harald Jüppner; Isidro B Salusky
Journal:  Nephrol Dial Transplant       Date:  2011-03-25       Impact factor: 5.992

4.  Suggestion of a deficient osteoblastic function in diabetes mellitus: the possible cause of osteopenia in diabetics.

Authors:  H Rico; E R Hernandez; J A Cabranes; F Gomez-Castresana
Journal:  Calcif Tissue Int       Date:  1989-08       Impact factor: 4.333

Review 5.  CKD-MBD after kidney transplantation.

Authors:  Katherine Wesseling-Perry; Justine Bacchetta
Journal:  Pediatr Nephrol       Date:  2011-03-11       Impact factor: 3.714

6.  The Importance of Biologically Active Vitamin D for Mineralization by Osteocytes After Parathyroidectomy for Renal Hyperparathyroidism.

Authors:  Aiji Yajima; Ken Tsuchiya; David B Burr; Joseph M Wallace; John D Damrath; Masaaki Inaba; Yoshihiro Tominaga; Shigeru Satoh; Takashi Nakayama; Tatsuhiko Tanizawa; Hajime Ogawa; Akemi Ito; Kosaku Nitta
Journal:  JBMR Plus       Date:  2019-10-23

7.  Hyperglycemia induces endoplasmic reticulum stress-dependent CHOP expression in osteoblasts.

Authors:  Wei Liu; Xiaoqing Zhu; Qian Wang; Linlin Wang
Journal:  Exp Ther Med       Date:  2013-02-27       Impact factor: 2.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.